(Q44056198)

29 November 2017

title

Stage-specific antimalarial activity of cysteine protease inhibitors (English)

1 reference

29 November 2017

0 references

Philip J Rosenthal

1 reference

29 November 2017

Bhaskar R Shenai

1 reference

29 November 2017

Andrey V Semenov

series ordinal

1 reference

29 November 2017

publication date

1 May 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

383

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

843-847

1 reference

Recombinant falcipain-2 cleaves erythrocyte membrane ankyrin and protein 4.1.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Hemoglobin metabolism in the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Plasmodium knowlesi: studies on invasion of rhesus erythrocytes by merozoites in the presence of protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Structure-based inhibitor design by using protein models for the development of antiparasitic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Identification of three stage-specific proteinases of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

Human malaria parasites in continuous culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2002.089

21 January 2018

Identifiers

DOI

10.1515/BC.2002.089

1 reference

29 November 2017

1 reference